Octreotide for acute esophageal variceal bleeding: A meta-analysis

Corley, 1995, Upper gastrointestinal hemorrhage (UGIH): predicting rebleeding from non-endoscopic clinical parameters, Gastroenterology, 108, A9, 10.1016/0016-5085(95)22701-6 Avgerinos, 1998, Approach to the management of bleeding esophageal varices: role of somatostatin, Digestion, 59, 1, 10.1159/000051408 Imperiale, 1995, A meta-analysis of somatostatin versus vasopressin in the management of acute esophageal variceal hemorrhage, Gastroenterology, 109, 1289, 10.1016/0016-5085(95)90590-1 Gotzsche, 1995, Somatostatin v placebo in bleeding oesophageal varices: randomised trial and meta-analysis, BMJ, 310, 1495, 10.1136/bmj.310.6993.1495 Avgerinos, 1995, Somatostatin or octreotide versus endoscopic sclerotherapy in acute variceal haemorrhage: a meta-analysis study, J Hepatol, 22, 247, 10.1016/0168-8278(95)80436-6 Avgerinos, 1995, Somatostatin and octreotide in the management of acute variceal hemorrhage, Hepatogastroenterology, 42, 145 Ludwig, 2000, 48-Hour hemodynamic effects of octreotide on postprandial splanchnic hyperemia in patients with liver cirrhosis and portal hypertension: double-blind, placebo-controlled study, Dig Dis Sci, 45, 1019, 10.1023/A:1005553914878 Schiedermaier, 1999, Effects of different octreotide dosages on splanchnic hemodynamics and glucagon in healthy volunteers, Digestion, 60, 132, 10.1159/000007638 Signorelli, 1996, Sclerotherapy with or without somatostatin or octreotide in the treatment of acute variceal haemorrhage: our experience, Gastroenterology, 110, A1326 Besson, 1995, Sclerotherapy with or without octreotide for acute variceal bleeding, N Engl J Med, 333, 555, 10.1056/NEJM199508313330904 Hwang, 1992, A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding, J Hepatol, 16, 320, 10.1016/S0168-8278(05)80663-4 Huang, 1992, A prospective randomized controlled trial of sandostatin and vasopressin in the management of acute bleeding esophageal varices, Chang Keng I Hsueh, 15, 78 McKee, 1992, A comparison of SMS 201-995 and oesophageal tamponade in the control of acute variceal haemorrhage, HPB Surg, 6, 7, 10.1155/1992/76345 Pedretti, 1994, Octreotide versus terlipressin in acute variceal hemorrhage in liver cirrhosis. Emergency control and prevention of early rebleeding, Clin Invest, 72, 653, 10.1007/BF00212982 Sung, 1993, Octreotide infusion or emergency sclerotherapy for variceal haemorrhage, Lancet, 342, 637, 10.1016/0140-6736(93)91758-E Sung, 1995, Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation, Lancet, 346, 1666, 10.1016/S0140-6736(95)92840-5 Silvain, 1993, Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: a multicenter randomized trial, Hepatology, 18, 61 Jenkins, 1997, A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage, Gut, 41, 526, 10.1136/gut.41.4.526 Chan, 1997, Review article: the role of pharmaco-therapy for acute variceal haemorrhage in the era of endoscopic haemostasis, Aliment Pharmacol Ther, 11, 45, 10.1046/j.1365-2036.1997.122293000.x Katkov, 1994, Hold that needle: octreotide for acute variceal hemorrhage, Hepatology, 19, 1051 Primignani, 1995, Sclerotherapy plus octreotide versus sclerotherapy alone in the prevention of early rebleeding from esophageal varices: a randomized, double-blind, placebo-controlled, multicenter trial. New Italian Endoscopic Club, Hepatology, 21, 1322, 10.1016/0270-9139(95)90054-3 Burroughs, 1996, Double blind RCT of 5 day octreotide versus placebo, associated with sclerotherapy for trial/failures, Hepatology, 24, 352A Campisi, 1993, Upper digestive hemorrhage. Comparison of terlipressin and octreotide, Minerva Chir, 48, 1091 Imperiale, 1997, Somatostatin or octreotide compared with H2 antagonists and placebo in the management of acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis, Ann Intern Med, 127, 1062, 10.7326/0003-4819-127-12-199712150-00002 Gerbarg, 1988, Resolving conflicting clinical trials: guidelines for meta-analysis, J Clin Epidemiol, 41, 503, 10.1016/0895-4356(88)90053-4 Jadad, 1996, Assessing the quality of reports of randomized clinical trials: is blinding necessary?, Control Clin Trials, 17, 1, 10.1016/0197-2456(95)00134-4 Chalmers, 1983, Bias in treatment assignment in controlled clinical trials, N Engl J Med, 309, 1358, 10.1056/NEJM198312013092204 Schulz, 1994, Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals, JAMA, 272, 125, 10.1001/jama.1994.03520020051014 Schulz, 1995, Empirical evidence of bias., JAMA, 273, 408, 10.1001/jama.1995.03520290060030 Imperiale, 1999, Meta-analysis: when and how, Hepatology, 29, 26S Petitti, 1994 DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2 Kendall, 1990 Gleser, 1996, Models for estimating the number of unpublished studies, Stat Med, 15, 2493, 10.1002/(SICI)1097-0258(19961215)15:23<2493::AID-SIM381>3.0.CO;2-C El-Jackie, 1998, Octreotide vs. sclerotherapy in the control of acute variceal bleeding in schistosomal portal hypertension: a randomized trial, Hepatology, 28, 553A Kosumobroto, 1994, Comparison of octreotide, vasopressin and SB tube for acute bleeding of esophageal varices. A prospective randomized trial, J Gastroenterol Hepatol, 9, A34 Signorelli, 1997, Esophageal varices bleeding: comparison between treatment with sclerotherapy alone vs sclerotherapy plus octreotide, Hepatology, 26, 137A Zuberi, 2000, Comparison of endoscopic variceal sclerotherapy alone and in combination with octreotide in controlling acute variceal hemorrhage and early rebleeding in patients with low-risk cirrhosis, Am J Gastroenterol, 95, 768, 10.1111/j.1572-0241.2000.01858.x McKee, 1993, Sandostatin therapy of acute oesophageal variceal bleeding, Digestion, 54, 27, 10.1159/000201072 Lo, 1997, Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices, Hepatology, 25, 1101, 10.1002/hep.510250509 Heresbach, 1995, Sclerotherapy versus ligation in hemorrhage caused by rupture of esophageal varices. Direct meta-analysis of randomized trials, Gastroenterol Clin Biol, 19, 914